As hospitals and technology vendors make strides forward into precision medicine, healthcare CIOs now have a new task at hand: integrating more tools into the clinical workflow.
Translational Software became the latest in a growing rank of vendors and innovators creating systems that help advance precision medicine on Monday when it introduced the PGx pediatric platform.
Last week, for instance, CureMatch announced that its system bested doctors at determining personalized cancer treatments. The list of precision medicine tools also includes such organizations as Neurotrack, which built a system that uses eye-tracking technology to predict and help prevent the development of Alzheimer’s; and Intermountain Precision Genomics, which is working with 10x Genomics to bring personalized medicine from the lab bench to clinical practice. And those are just the tools to emerge within the last several weeks.
Translational Software, for its part, built PGx in conjunction with Inova Genomics Laboratory. The organizations described PGx as a system and testing panel that hospitals can use to predict how a child might react to specific medications by evaluating seven actionable genes. TSI also has a FHIR-based PGx API that integrates access to their pharmacogenomics solutions with existing e-prescribing and EHR systems.